Navigation Links
Research presented at ISHLT shows promise of addressing critical organ shortage and
Date:4/10/2008

Boston, MA April 10, 2008 Data from experimental work on the use of organs from cardiac arrested donors will be presented this week at the International Society for Heart and Lung Transplantations 28th Annual Meeting and Scientific Sessions. Utilizing donors after cardiac death (DCD), also known as non-heart-beating donors (NHBDs) has the potential to overcome a critical shortage of suitable donor organs for lung, and possibly heart, transplantation.

In addition, strategies for organ preservation during transport from donor to recipient will be a primary topic of discussion at the ISHLT meeting running through Saturday at the Boston Marriott Copley Place and Hynes Convention Center.

There is a worldwide shortage of quality donor organs for transplantation. This year, we are going to hear about clinical updates on non-heart-beating lung donors, and also exciting new experimental work on the possible use of hearts from cardiac-arrested donors, said Steven Tsui, M.D., F.R.C.S., Director of Transplantation and Surgeon, Papworth Hospital, U.K. In addition, there has been a lot of interest in techniques aiming to maintain, and possibly improve, donor organ function once they have been removed from the donor.

NON-HEART-BEATING DONORS

Organ transplantation is currently limited by a shortage of suitable donors, which results in longer waiting times for patients and a substantial risk of dying before transplantation.

Promising research results suggest the potential to immediately increase the number of lungs available for transplantation. Although thousands of patients are on lung transplant waiting lists around the world, only a small percentage actually receive transplants. And likewise, a small proportion of individuals identified as organ donors actually have suitable lungs for transplantation.

During the ISHLT mini-oral session I: The Non-Heart Beating Donor for Heart Transplantation, Ayyaz Ali
'/>"/>

Contact: Lauren Mason
lmason@masonpr.com
210-857-2521
International Society for Heart and Lung Transplantation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. DeBakey Awards to Recognize Excellence in Biomedical Research Journalism
2. Deafness Research Foundation 50th Anniversary Celebration
3. Researchers pilot new electronic system for infectious illness
4. Researchers Find Gene Mutation That Increases Asthma Risk
5. How fast youll age is written in the bones, TAU research finds
6. Boston College biologists build a better mouse model for cancer research
7. Massachusetts Affiliate of Susan G. Komen for the Cure to Spotlight Gaps in Breast Cancer Research
8. Researchers Define Mechanism of Methamphetamine Addiction
9. New research shows neuroprotective effect of lovastatin
10. Attacks against medical researchers: Time to take a stand
11. New research for mechanical support devices in pediatrics to be released at ISHLT
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5NMB 26apos 3Bs New Series of Standard Hybrid Stepper Motors Now Available 54875 1NMB 26apos 3Bs New Series of Standard Hybrid Stepper Motors Now Available 54875 2National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 54871 1National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 54871 2National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 54871 3Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 1Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 2Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 3Aton Pharma Launches Expanded Distribution and Marketing for Preservative Free TIMOPTIC 28R 29 in OCUDOSE 28R 29 54867 4